Founded in 2003 by Dr. Shlomo Ben-Haim, MetaCure has developed an implantable medical device system for the treatment of type 2 diabetes and obesity.
MetaCure is one of the portfolio companies of the Hobart Group, which invests in medical device companies [REF].